Epithalon (Epitalon) is used by the longevity community in an annual 10-day course protocol, based on the original Russian clinical research by Dr. Vladimir Khavinson. This article covers community experience reports for this protocol.
The Annual Course Protocol
The most commonly reported community protocol is 5–10mg daily for 10 consecutive days, once or twice per year. This mirrors the dosing used in the original clinical research. SubQ injection is the most common administration method, though IV is also reported.
Reported Effects
The most consistently reported early effect is improved sleep quality and vivid dreams, typically beginning within the first few days of the course. Over the weeks following the course, community members report improved energy, skin quality, and immune function. Longer-term effects (telomere lengthening, biological age reduction) are not directly measurable by most users but are the primary motivation for the longevity-focused community.
Stacking with Other Longevity Peptides
Many community members stack Epithalon with NAD+ (for mitochondrial support) and GHK-Cu (for epigenetic effects) as part of a comprehensive longevity protocol. Physician-supervised longevity protocols through Alukard can help design and monitor a comprehensive approach.